Sia et al. reported that about 25% of HCC cases had a subtype of an immune class characterized by immune activation, with overexpression of adaptive immune response genes, such as CD8A, CD3E, IFNG, CXCL9, and others, termed the active immune response subtype. This evidence concerns the gene CD8A and hepatocellular carcinoma.